Last reviewed · How we verify
Phenoterol (FENOTEROL)
At a glance
| Generic name | FENOTEROL |
|---|---|
| Drug class | fenoterol |
| Target | Beta-2 adrenergic receptor, Beta-2 adrenergic receptor |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Functional Strength Training and Neuromuscular Electrical Stimulation in Severe Acute Exacerbations of COPD (NA)
- Continuous Versus Intermittent Nebulization Therapy in Acute Asthma Exacerbation at Emergency Department (NA)
- Prehospital Non-invasive Ventilation for Acute Exacerbation of Chronic Obstructive Pulmonary Disease (NA)
- Bronchodilators on the Exercise Capacity of Bronchiectasis Patients (NA)
- Beta 2 Adrenergic Stimulation vs Cold Exposure to Activate Human Brown Adipose Tissue (EARLY_PHASE1)
- Individualized Dosing Schedule of Inhaled Bronchodilator for Endotracheally Intubated COPD Patients (NA)
- Aerosol Therapy in Obese COPD Patients. (NA)
- Different Positive Pressure Strategies in COPD Patients. (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Phenoterol CI brief — competitive landscape report
- Phenoterol updates RSS · CI watch RSS